Table 3.

Cumulative Risk of Prostate Cancer Diagnosis for ATM and CHEK2 mutation carriers.

Percentage Cumulative Risk (95% CI) of Prostate Cancer Diagnosis
Age (Years)	ATM Mutation Carriers	CHEK2 Mutation Carriers
30	0 (0–0)	0 (0–0.1)
40	0 (0–0)	0 (0–0.4)
50	0.5 (0.1–2.5)	1.2 (0.1–22.4)
60	5.7 (1.1–25.9)	13.2 (0.7–95)
70	20.6 (4.4–69.4)	42.8 (2.6–100)
80	40.9 (9.7–93.3)	72.1 (5.8–100)